Sunovion Announces Upcoming Availability of ZETONNA (ciclesonide) Nasal Aerosol, a Non-Aqueous, Dry Nasal Aerosol Spray for Allergic Rhinitis - Phramalive.com

ZETONNA TM (ciclesonide) Nasal Aerosol will be the third ciclesonide formulation marketed by Sunovion, with the others being ALVESCO® (ciclesonide) Inhalation Aerosol in an HFA formulation for the maintenance treatment of asthma in adults and adolescents ...

Sunovion Announces Upcoming Availability of ZETONNA™ (ciclesonide) Nasal Aerosol, a Non-Aqueous, Dry Nasal Aerosol Spray for Allergic Rhinitis - Boston Globe

ZETONNATM (ciclesonide) Nasal Aerosol will be the third ciclesonide formulation marketed by Sunovion, with the others being ALVESCO® (ciclesonide) Inhalation Aerosol in an HFA formulation for the maintenance treatment of asthma in adults and ...

Zetonna Available Soon for Allergic Rhinitis - Monthly Prescribing Reference

Zetonna contains the same active ingredient found in Sunovion's Omnaris nasal spray, a hypotonic formulation indicated for the treatment of SAR and PAR, and Alvesco inhalation aerosol, indicated for the maintenance treatment of asthma. Zetonna will be ...

Sunovion Announces Upcoming Availability of ZETONNA(TM) (ciclesonide) Nasal Aerosol, a Non-Aqueous, Dry Nasal Aerosol Spray for Allergic Rhinitis - Marketwatch

About Ciclesonide ZETONNA(TM) (ciclesonide) Nasal Aerosol will be the third ciclesonide formulation marketed by Sunovion, with the others being ALVESCO(R) (ciclesonide) Inhalation Aerosol in an HFA formulation for the maintenance treatment of ...

New Study Shows Patients Can Effectively be Switched to Latuda® (lurasidone HCl) from Other Antipsychotic Agents - Genetic Engineering News

LATUDAis a registered trademark of Dainippon Sumitomo Pharma Co., Ltd. LUNESTA, XOPENEX, XOPENEX HFA and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc. OMNARIS and ALVESCO are registered trademarks of Nycomed GmbH.

Latuda® (lurasidone HCl) Label Updated With Expanded Dosing Range Providing Added Flexibility for the Treatment of Patients with Schizophrenia - Fort Mill Times

LATUDA is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd. LUNESTA, XOPENEX, XOPENEX HFA and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc. OMNARIS and ALVESCO are registered trademarks of Nycomed GmbH.

Dainippon Sumitomo Pharma Reports that Latuda (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase III Trials in Bipolar I Depression - Phramalive.com

LATUDA is a registered trademark of Dainippon Sumitomo Pharma Co., Ltd. LUNESTA, XOPENEX, XOPENEX HFA and BROVANA are registered trademarks of Sunovion Pharmaceuticals Inc. OMNARIS and ALVESCO are registered trademarks of Nycomed GmbH.